Welcome to this week’s issue of AI: The Washington Report, a joint undertaking of Mintz and its government affairs affiliate,…
Read More →
n October 30, President Biden issued the long-awaited Executive Order on the Safe, Secure, and Trustworthy Development and Use of…
Read More →
On October 30, 2023, President Biden published a landmark Executive Order regarding the use of Artificial Intelligence (“AI”) with an…
Read More →
On October 25, 2023, the Patented Medicine Prices Review Board (PMPRB) announced that it will launch the first phase of…
Read More →
On October 30, 2023, President Joe Biden signed his Executive Order on the Safe, Secure, and Trustworthy Development and Use…
Read More →
D.R. by Rodriguez v. Santos Bakery, Inc., No. 20-CV-3628 (KHP), 2023 WL 3736441 (S.D.N.Y. May 31, 2023) – This decision…
Read More →
Depression during pregnancy, or prepartum depression, is a common condition that an estimated ten percent of women in the United…
Read More →
Roundup Users With Lymphoma May Qualify to File a Lawsuit Following Verdicts Against Bayer, Monsanto
Juries in Philadelphia and San Diego recently awarded damages of $175 million and $332 million to two men who were…
Read More →
The U.S. Food and Drug Administration’s (FDA’s) broad definition of “misbranding” has created some industry confusion, while the Federal Trade…
Read More →
The Biden Administration announced a broad Executive Order (Order) on artificial intelligence (AI). The Order, announced just days before an…
Read More →